Jenny Wigén
1 – 10 of 19
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Extracellular Matrix as a Driver of Chronic Lung Diseases
2024) In American Journal of Respiratory Cell and Molecular Biology(
- Contribution to journal › Article
- 2023
-
Mark
Pulmonary 5-HT
2B receptor expression in fibrotic interstitial lung diseases.
(
- Contribution to journal › Article
-
Mark
Is classifying SSc-ILD drugs as either immunosuppressive or anti-fibrotic misleading?
(
- Contribution to journal › Letter
- 2021
-
Mark
Pathological insight into 5-ht2b receptor activation in fibrosing interstitial lung diseases
(
- Contribution to journal › Scientific review
-
Mark
Protein signatures of remodeled airways in transplanted lungs with Bronchiolitis Obliterans Syndrome obtained using laser capture microdissection
(
- Contribution to journal › Article
-
Mark
Harnessing the ECM Microenvironment to Ameliorate Mesenchymal Stromal Cell-Based Therapy in Chronic Lung Diseases
(
- Contribution to journal › Scientific review
- 2020
-
Mark
Converging pathways in pulmonary fibrosis and Covid-19 - The fibrotic link to disease severity : Common molecular pathways in Covid-19 and pulmonary fibrosis
(
- Contribution to journal › Article
- 2019
-
Mark
Glycosaminoglycans: a link between development and regeneration in the lung : a link between development and regeneration in the lung
(
- Contribution to journal › Article
- 2015
-
Mark
ROS-induced endothelial stress contributes to pulmonary fibrosis through pericytes and Wnt signaling.
2015) In Laboratory Investigation(
- Contribution to journal › Article
-
Mark
Versican in inflammation and tissue remodelling: the impact on lung disorders.
(
- Contribution to journal › Scientific review